Prominent corneal nerves are a diagnostic feature of LP

Article

Prominent corneal nerves have been identified as a diagnostic feature of lipid proteinosis (LP)

Prominent corneal nerves have been identified as a diagnostic feature of lipid proteinosis (LP), claims a study in the British Journal of Ophthalmology.

Dr Yasser H. Al-Faky et al., Ophthalmology Department, College of Medicine, King Saud University, Saudi Arabia, conducted a detailed longitudinal evaluation of seven LP patients and nine unaffected individuals. The Nidek confoScan 4 and direct sequencing of the extracellular matrix protein 1 gene was used to perform confocal microscopic examinations.

All LP patients had homozygous mutations in extracellular matrix protein 1 and four patients were examined every six months, starting from infancy. It was discovered that globe and vision were normal in all particpants, with moniliform blepharosis appearing after four years of age.

All patients presented with prominent corneal nerves, regardless of age. The corneal nerves were more prominent in patients with severe genetic mutations. Severity of moniliform blepharosis appeared to be more affected by age rather than genotype.

The discovery of prominent corneal nerves as a diagnostic feature can be used to detect LP at a much earlier stage.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.